Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic
Radiotherapy and Oncology(2020)
摘要
Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing radiotherapy fractions for cervical cancer patients.
更多查看译文
关键词
Covid-19,Radiotherapy,Hypofractionation,Cervical cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要